Genetic reasons behind Raynaud’s phenomenon discovered

FHS
August 4, 2023
11:56 am

Researchers at Queen Mary University of London’s Precision Healthcare Research Institute (PHURI) and the Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin have identified the genetic causes of Raynaud’s phenomenon.

New insights into lasso peptides offer promise for drug development

Lasso peptides are natural products made by bacteria. Their unusual lasso shape endows them with remarkable stability, protecting them from extreme conditions

September 20, 2024

Coeptis licenses Deverra Therapeutics’ clinical stage assets

DVX201 is being assessed in a Phase I clinical study for treating haematologic malignancies and viral infections. Credit: Kateryna Kon/Shutterstock.com. Coeptis Therapeutics has exclusively licensed

August 18, 2023

A hot summer linked to high risk of dying from malaria in the following year

As climate change accelerates, it is becoming increasingly important to study the impact of climate change on human health.

September 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.